Diagnostic imaging have witnessed revolutionary advancement from monitoring the patient to digital scanning of the organs. The diagnostic imaging devices are primarily used to imaging the human body with the help of many imaging technologies. Medical diagnostic imaging is the technique used to create visual presentation of internal organs of body for clinical analysis and medical interventions. These devices are used to monitor, screen, diagnose and treat various medical conditions for effective medical intervention. And this is helpful for the detection or diagnosis of diseases in the body and is used to study the structure and function of different organs and cells.  Diseases which were not easy to diagnose years before have become easy to detect with this technique. Global diagnostic imaging devices market generated revenue of $26.38 billion in 2016, and is expected to reach up to $39.45 billion in 2023 at a CAGR of 6.7%. Some of the drivers which are boosting the market are increasing number of Diagnostic Imaging Centers, increasing aging population, technological advancement of diagnostic imaging modalities.  Factors such as increased incidences of chronic diseases, awareness related to diseases, improved healthcare sectors are boosting the growth of diagnostic imaging market. Increase in the demand of economic and eco-friendly diagnostic devices among medical professional which are easy to use and provide result on time are the major factor increasing the demand of diagnostic imaging devices market. However, strict government regulation and increasing risk of cancer due to exposure to radiation are primary restraint for the growth of this market.   Remanufactured imaging devices such as endoscopy equipment, neurology equipment, X-ray machines, MRI machines etc. are expected to witness an impressive growth in coming years. Medical imaging devices are one of the highest revenue generating product segment due to the increased usage of diagnostic imaging devices for diagnosis of chronic diseases such as cancer and heart disorders and the market is expected to grow over the forecast period owing to the rapidly increasing heart and lung diseases globally. Moreover advanced imaging technologies such as magnetic particle imaging have developed a better option for the diagnostic purpose.

Due to the increase in number of chronic cases such as COPD, cardiovascular diseases, asthma and multiple sclerosis, cancer  increased the demand of diagnosis globally which increased the market of diagnostic imaging machines worldwide.  According to WHO it is estimated that around 3 million deaths were caused by COPD globally. More than 90% of death occurred in low and middle income countries.  Cardio vascular diseases are world’s biggest killer, WHO estimates that 17.5 million people die each year from cardiovascular diseases, accounting for around 31% of death worldwide. Rise in the number of these diseases increasing the market of diagnostic imaging devices.  According to world health organization in 2015 it has seen that in the U.S. more than 1658370 new cancer cases had come in which more than 848200 male cancer cases are there and 810170 female cancer cases. It has also witnessed  that more than 589430 death has caused due to cancer in which more than 312150 are male and 277280 are female. In India  in 2015 more than 666,563 death has caused due to cancer in which 305,000 are females and 361,474 are male Due to increasing chronic cases and deaths  demand of medical checkup has also increased which ultimately increased the market of diagnostic imaging equipments..   The increasing aging population worldwide also become the major factor which increase the market of diagnostic imaging devices globally.

The global diagnostic imaging device market on the basis of application is divided into X ray imaging system application in radiography. MRI system application is various diseases in cardiac, brain and neurological diseases, vascular and pelvic, ultrasound system in radiology, vascular urology etc., CT scanners and nuclear imaging system in oncology and neurology, cardiology etc. On the basis of end user the it is segmented into hospitals, diagnostic centers and others.

Geographically the market is segmented into North America, Europe, Asia Pacific and ROW. North America is the dominating the global diagnostic imaging devices market. Due to increasing patient of chronic diseases lifestyle disorders with growing genetic disorders , advancement of technology and increasing in R& D expenditure helps to increase the market. Improved healthcare infrastructure, awareness about releases among people are another factor driving the market in the region. Europe is the leading region due to increased healthcare facilities, increased fund for research and development and increase in diseases. Europe is expected to gain the largest market share in coming years.. Asia Pacific is one of the fastest growing region. India and China are the two emerging countries in region having numerous growth opportunities. Factors such as  increasing healthcare expenditure, growing geriatric population, increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries helps to accelerate the market of diagnostic imaging devices.  Medical tourism is one of the growth factor in this region.

Some of the key players of diagnostic imaging device market includes Fujifilm Technologies Of Japan , Carestrean  Of United States , Ge Health Care Of United Kingdom  , Hitachi Of Japan  ,Esaote , Cardinal Health  Of Dublin , Bracco Of Italy  , Hologic  Of United States etc. Innovation and expansion are some of the key strategies being adopted by the market players. For example hologic acquire cynosure which is known for medical aesthetic systems. This acquisition will expand their business by entering into a medical aesthetic system market, which leads to their strong position in the OB/GYN and women health segment, more financial benefits. More over this acquisition will lead to innovation, can have the range of market leading products because cynosure has a portfolio of more than 20 products with demonstrated clinical advantages in women health sector, strong customer base. On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments. North America has the largest market share of 33.4% followed by Europe and Asia Pacific. Due to improving healthcare infrastructure & healthcare spending, improving reimbursement and insurance coverage facilities, and large number of ongoing research activities in the region helps to increase the market.

 

On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION AND SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360 DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        PRICING ANALYSIS

2.7.6.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES AND ANALYSIS

2.8.2.        MARKET SHARE

2.8.3.        TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        AGING POPULATIONS

3.1.2.        INCREASE IN LIFESTYLE AND CHRONIC DISEASES

3.1.3.        INCREASING DIAGONISTIC CENTRES

3.1.4.         INCREASES INCIDENCE OF CANCER CASES

3.1.5.        GROWING GERIARTIC POPULATIONS

 

3.2. MARKET RESTRAINTS

3.2.1.         EXPENSIVE DIAGONISTIC IMAGING SYSTEMS

3.2.2.         LIMITATION IN TERMS OF TECHNOLOGY ASSOSIATED WITH STANDALONE SYSTEMS

3.3. MARKET OPPORTUNITIES

3.3.1.        INCRESING DEMAND OF DIAGONISTIC IMAGING DEVICES

3.3.2.        GROWING MEDICAL TOURISM AND IMPROVEMENT IN HEALTH CARE INFRASTRUCTURE

3.3.3.        TECHNOLOGIACAL ADVANCEMENT IN DIAGONISTIC IMAGING  DEVICES

3.4. MARKET CHALLENGES

3.4.1.        LACK OF TRAINED PERSONNEL

3.4.2.        INCREASING ADOPTION OF REFURBISHED DIAGONISTIC SYSTEMS

4.       MARKET SEGMENTATION

4.1.            GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY PRODUCT TYPE

4.1.1.        MARKET DEFINITION AND SCOPE

4.1.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.4.         OPPORTUNITY MATRIX

4.1.5.         MARKET SEGMENTATION

4.1.5.1.                        X-RAY  IMAGING SYSTEMS

4.1.5.1.1.        APPLICATIONS

4.1.5.1.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.1.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.1.4.        TOP PLAYERS & KEY PRODUCTS

4.1.5.1.5.        KEY CONCLUSIONS

4.1.5.1.6.                  SUB SEGMENTS

4.1.5.1.6.1.1.         X RAY IMAGING SYSTEM BY TECHNOLOGY

4.1.5.1.6.1.1.1.                DIGITAL IMAGONH

4.1.5.1.6.1.1.2.                DIRECT RADIOGRAPHY

4.1.5.1.6.1.1.3.                COMPUTED RADIO GRAPHY

4.1.5.1.6.2.   X RAY IMAGING SYSTEM BY PORTABILITY

4.1.5.1.6.2.1.         STATIONARY

4.1.5.1.6.2.2.         PORTABLE

 

 

 

4.1.5.2.                        ULTRASOUND IMAGING SYSTEMS

4.1.5.2.1.        APPLICATIONS

4.1.5.2.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.2.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.2.4.        TOP PLAYERS & KEY PRODUCTS

4.1.5.2.5.        KEY CONCLUSIONS

4.1.5.2.6.        SUB SEGMENTS

4.1.5.2.6.1.   ULTRASOUND IMAGING SYSTEM BY TECHNOLOGY

4.1.5.2.6.1.1.         2 D IMAGING

4.1.5.2.6.1.2.         3D AND 4D IMAGING

4.1.5.2.6.1.3.         DOPPLER IMAGING

4.1.5.2.6.2.   ULTRASOUND IMAGING SYSTEM BY PORTABILITY

4.1.5.2.6.2.1.         TROLLEY CART BASED ULTRASOUND SYSTEM

4.1.5.2.6.2.2.         COMPACT  ULTRASOUND SYSTEM

4.1.5.3.                        MAGNETIC RESONANCE IMAGING

4.1.5.3.1.        APPLICATIONS

4.1.5.3.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.3.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.3.4.        TOP PLAYERS & KEY PRODUCTS

4.1.5.3.5.        KEY CONCLUSIONS

4.1.5.3.6.      SUBSEGMENTS

4.1.5.3.6.1.            MRI SYSTEM MARKET  BY ARCHITECTURE

4.1.5.3.6.1.1.      CLOSEDE MRI

4.1.5.3.6.1.2.      OPEN MRI

4.1.5.3.6.2.            MRI SYSTEM MARKET BY FIELD STRENGTH

4.1.5.3.6.2.1.      HIGH AND VERY HIGH FIELD MRI SYSTEMS

4.1.5.3.6.2.2.      LOW TO MILD FIEKLD MRI SYSTEMS

4.1.5.3.6.2.3.      ULTRA HIGH FIELD MRI SYSTEM

4.1.5.4.                        COMPUTED TOMOGRAPHY (CT) SCANNERS

4.1.5.4.1.        APPLICATIONS

4.1.5.4.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.4.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.4.4.        TOP PLAYERS & KEY PRODUCTS

4.1.5.4.5.        KEY CONCLUSIONS

4.1.5.4.6.        SUBSEGMENTES

4.1.5.4.6.1.   CT SCANNERS MARKET BY SLICE TYPE

4.1.5.4.6.1.1.         HIGH SLICE CT SCANNERS

4.1.5.4.6.1.2.         MID SLICE CT SCANNERS

4.1.5.4.6.1.3.         LOW SLICE CT SXCANNERS

4.1.5.5.                        NUCLEAR IMAGING SYSTEM

4.1.5.5.1.        APPLICATIONS

4.1.5.5.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.5.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.5.4.        TOP PLAYERS & KEY PRODUCTS

4.1.5.5.5.        KEY CONCLUSIONS

4.1.5.5.6.        SUBSEGMENTES

4.1.5.5.6.1.   SPECT SYSTEM

4.1.5.5.6.1.1.         HYBRID SPECT SYSTEM

4.1.5.5.6.1.2.         STANDALONE SPECT SYSTEM

4.1.5.5.6.2.   HYBRID PET SYSTEM

4.2. GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY APPLICATION

4.2.1.        MARKET DEFINITION AND SCOPE

4.2.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4.         OPPORTUNITY MATRIX

4.2.5.         MARKET SEGMENTATION

4.2.5.1.                        X RAY IMAGING SYSTEM

4.2.5.1.1.        APPLICATIONS

4.2.5.1.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5.        KEY CONCLUSIONS

4.2.5.2.                        MAGNETIC RESONANCE  IMAGING SYSTEM

4.2.5.2.1.        APPLICATIONS

4.2.5.2.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5.        KEY CONCLUSIONS

4.2.5.3.                         ULTRASOUND IMAGING SYSTEM

4.2.5.3.1.        APPLICATIONS

4.2.5.3.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5.        KEY CONCLUSIONS

4.2.5.4.                        COMPUTED TOMOGRAPHY SCANNERS

4.2.5.4.1.        APPLICATIONS

4.2.5.4.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5.        KEY CONCLUSIONS

4.2.5.5.                        NUCLEAR IMAGING SYSTEM

4.2.5.5.1.        APPLICATIONS

4.2.5.5.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.5.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.5.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.5.5.        KEY CONCLUSIONS

 

 

4.3. GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY MAJOR END USRERS

4.3.1.        MARKET DEFINITION AND SCOPE

4.3.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4.         OPPORTUNITY MATRIX

4.3.5.         MARKET SEGMENTATION

4.3.5.1.                        HOSPITALS

4.3.5.1.1.        APPLICATIONS

4.3.5.1.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4.        TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5.        KEY CONCLUSIONS

4.3.5.2.                        DIAGONISTIC  IMAGING CENTRE

4.3.5.2.1.        APPLICATIONS

4.3.5.2.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4.        TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5.        KEY CONCLUSIONS

4.3.5.3.                        OTHER END USERS

4.3.5.3.1.        APPLICATIONS

4.3.5.3.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.4.        TOP PLAYERS & KEY PRODUCTS

4.3.5.3.5.        KEY CONCLUSIONS

 

5.       COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1.        LIST OF M&A

5.1.2.        LIST OF JV

5.1.3.        LIST OF PRODUCT LAUNCHES

5.1.4.        LIST OF PARTNERSHIP

5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD

6.      GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY REGION

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4.  GEOGRAPHIC SEGMENTATION

6.4.1.      NORTH AMERICA

6.4.1.1.  INDUSTRY APPLICATION ANALYSIS

6.4.1.2.  TOP COUNTRY ANALYSIS

6.4.1.2.1.      U.S.

6.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.1.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3.   KEY CONCLUSIONS

6.4.1.2.2.      CANADA

6.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.1.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3.   KEY CONCLUSIONS

6.4.2.      EUROPE

6.4.2.1.  INDUSTRY APPLICATION ANALYSIS

6.4.2.2.  TOP COUNTRY ANALYSIS

6.4.2.2.1.      UK

6.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3.   KEY CONCLUSIONS

6.4.2.2.2.      FRANCE

6.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3.   KEY CONCLUSIONS

6.4.2.2.3.      GERMANY

6.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3.   KEY CONCLUSIONS

6.4.2.2.4.      SPAIN

6.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3.   KEY CONCLUSIONS

6.4.2.2.5.      ITALY

6.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3.   KEY CONCLUSIONS

6.4.2.2.6.      REST OF EUROPE

6.4.2.2.6.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.6.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.6.3.   KEY CONCLUSIONS

6.4.3.      ASIA PACIFIC

6.4.3.1.  INDUSTRY APPLICATION ANALYSIS

6.4.3.2.  TOP COUNTRY ANALYSIS

6.4.3.2.1.      CHINA

6.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3.   KEY CONCLUSIONS

6.4.3.2.2.      INDIA

6.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3.   KEY CONCLUSIONS

6.4.3.2.3.      JAPAN

6.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3.   KEY CONCLUSIONS

6.4.3.2.4.      SOUTH KOREA

6.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3.   KEY CONCLUSIONS

6.4.3.2.5.      AUSTRALIA

6.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3.   KEY CONCLUSIONS

6.4.3.2.6.      REST OF ASIA PACIFIC

6.4.3.2.6.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.6.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.6.3.   KEY CONCLUSIONS

6.4.4.      ROW

6.4.4.1.  INDUSTRY APPLICATION ANALYSIS

6.4.4.2.  TOP COUNTRY ANALYSIS

6.4.4.2.1.      LATIN AMERICA

6.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3.   KEY CONCLUSIONS

6.4.4.2.2.      MIDDLE EAST & AFRICA

6.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3.   KEY CONCLUSIONS

7.       COMPANY PROFILES

7.1. AGFA HEALTHCARE

 

7.1.1.          OVERVIEW

7.1.2.        PRODUCT PORTFOLIO

7.1.3.        KEY INNOVATION SECTOR

7.1.4.        STRATEGIC INITIATIVES

7.1.5.        SCOT ANALYSIS

7.1.6.        STRATEGIC ANALYSIS

7.2. ACERTARA

 

7.2.1.          OVERVIEW

7.2.2.        PRODUCT PORTFOLIO

7.2.3.        KEY INNOVATION SECTOR

7.2.4.        STRATEGIC INITIATIVES

7.2.5.        SCOT ANALYSIS

7.2.6.        STRATEGIC ANALYSIS

7.2.7.         

7.3.  BRACCO

7.3.1.        OVERVIEW

7.3.2.        PRODUCT PORTFOLIO

7.3.3.        KEY INNOVATION SECTOR

7.3.4.        STRATEGIC INITIATIVES

7.3.5.        SCOT ANALYSIS

7.3.6.        STRATEGIC ANALYSIS

7.4.  CARDINAL HEALTH

7.4.1.        OVERVIEW

7.4.2.        PRODUCT PORTFOLIO

7.4.3.        KEY INNOVATION SECTOR

7.4.4.        STRATEGIC INITIATIVES

7.4.5.        SCOT ANAL

7.4.6.        STRATEGIC ANALYSIS

7.5.  ESAOTE

7.5.1.        OVERVIEW

7.5.2.        PRODUCT PORTFOLIO

7.5.3.        KEY INNOVATION SECTOR

7.5.4.        STRATEGIC INITIATIVES

7.5.5.        SCOT ANALYSIS

7.5.6.        STRATEGIC ANALYSIS

7.6.  FUJIFILM  HOLDINGS 

7.6.1.        OVERVIEW

7.6.2.        PRODUCT PORTFOLIO

7.6.3.        KEY INNOVATION SECTOR

7.6.4.        STRATEGIC INITIATIVES

7.6.5.        SCOT ANALYSIS

7.6.6.        STRATEGIC ANALYSIS

7.7.  HOLOGIC

7.7.1.        OVERVIEW

7.7.2.        PRODUCT PORTFOLIO

7.7.3.        KEY INNOVATION SECTOR

7.7.4.        STRATEGIC INITIATIVES

7.7.5.        SCOT ANALYSIS

7.7.6.        STRATEGIC ANALYSIS

7.8. CARE STREAM HEALTH

7.8.1.        OVERVIEW

7.8.2.        PRODUCT PORTFOLIO

7.8.3.        KEY INNOVATION SECTOR

7.8.4.        STRATEGIC INITIATIVES

7.8.5.        SCOT ANALYSIS

7.8.6.        STRATEGIC ANALYSIS

7.9. GE HEALTH CARE

7.9.1.        OVERVIEW

7.9.2.        PRODUCT PORTFOLIO

7.9.3.        KEY INNOVATION SECTOR

7.9.4.        STRATEGIC INITIATIVES

7.9.5.        SCOT ANALYSIS

7.9.6.        STRATEGIC ANALYSIS

7.10.         HITACHI LTD

7.10.1.   OVERVIEW

7.10.2.   PRODUCT PORTFOLIO

7.10.3.   KEY INNOVATION SECTOR

7.10.4.   STRATEGIC INITIATIVES

7.10.5.   SCOT ANALYSIS

7.10.6.   STRATEGIC ANALYSIS

7.11.         PHILIPS HEALTH CARE

7.11.1.   OVERVIEW

7.11.2.   PRODUCT PORTFOLIO

7.11.3.   KEY INNOVATION SECTOR

7.11.4.   STRATEGIC INITIATIVES

7.11.5.   SCOT ANALYSIS

7.11.6.   STRATEGIC ANALYSIS

7.12.         SHIMADZU CORPORATIONS

7.12.1.   OVERVIEW

7.12.2.   PRODUCT PORTFOLIO

7.12.3.   KEY INNOVATION SECTOR

7.12.4.   STRATEGIC INITIATIVES

7.12.5.   SCOT ANALYSIS

7.12.6.   STRATEGIC ANALYSIS

7.13.         SIEMANS HEALTHCARE

7.13.1.   OVERVIEW

7.13.2.   PRODUCT PORTFOLIO

7.13.3.   KEY INNOVATION SECTOR

7.13.4.   STRATEGIC INITIATIVES

7.13.5.   SCOT ANALYSIS

7.13.6.   STRATEGIC ANALYSIS

7.14.         SPECTRANETICS CORPORATIONS

7.14.1.   OVERVIEW

7.14.2.   PRODUCT PORTFOLIO

7.14.3.   KEY INNOVATION SECTOR

7.14.4.   STRATEGIC INITIATIVES

7.14.5.   SCOT ANALYSIS

7.15.         TOSHIBA MEDICAL SYSTEMS AND CORPORATIONS

7.15.1.   OVERVIEW

7.15.2.   PRODUCT PORTFOLIO

7.15.3.   KEY INNOVATION SECTOR

7.15.4.   STRATEGIC INITIATIVES

7.15.5.   SCOT ANALYSIS

LIST OF TABLES

 

1.            GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  PRODUCT TYPE 2014-2023 ($MILLION)

2.            GLOBAL  X RAY IMAGING SYSTEM MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)

3.            GLOBAL   ULTRASOUND IMAGING SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

4.            GLOBAL   MRI SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

5.            GLOBAL   CT  SCANNERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

6.            GLOBAL  NUCLEAR IMAGING SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

7.            GLOBAL SMALL ANIMAL IMAGING MARKET  BY APPLICATION 2014-2023 ($ MILLION)

8.            GLOBAL  X RAY IMAGING SYSTEMS   MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9.            GLOBAL MRI IMAGING SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

10.        GLOBAL  ULTRASOUND SYSTEMS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

11.        GLOBAL CT SCANNER MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

12.        GLOBAL  NUCLEAR IMAGING SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

13.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY END USER  2014-2023 ($ MILLION)

14.        GLOBAL HOSPITAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

15.        GLOBAL  DIAGONISTIC IMAGING CENTRES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

16.        GLOBAL  OTHER ENDUSER  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

17.         

18.        NORTH AMERICA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

19.        EUROPE DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

20.        ASIA PACIFIC DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

21.        REST OF THE WORLD DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

LIST OF FIGURES

22.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY X RAY IMAGING SYSTEM 2014-2023 ($ MILLION)

23.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY MAGNETIC RESONANCE  IMAGING SYSTEM 2014-2023 ($ MILLION)

24.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  ULTRASOUND IMAGING SYSTEM 2014-2023 ($ MILLION)

25.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  CT SYSTEM 2014-2023 ($ MILLION)

26.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  NUCLEAR IMAGING SYSTEM 2014-2023 ($ MILLION)

27.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY X RAY IMAGING SYSTEM 2014-2023 ($ MILLION)

28.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  MAGNETIC RESONANCE IMAGING SYSTEMS 2014-2023 ($ MILLION)

29.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY ULTRASOUND SYSTEMS2014-2023 ($ MILLION)

30.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY ULTRASOUND SYSTEMS 2014-2023 ($ MILLION)

31.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY CT SCANNERS   2014-2023 ($ MILLION)

32.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY NUCLEAR IMAGING SYSTEM 2014-2023 ($ MILLION)

33.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY HOSPITAL 2014-2023 ($ MILLION)

34.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY  DIAGONISTIC IMAGING CENTRE 2014-2023 ($ MILLION)

35.        GLOBAL DIAGNOSTIC IMAGING DEVICESMARKET BY OTHER  END USERS 2014-2023 ($ MILLION)

 

36.        UNITED STATES (U.S.) DIAGNOSTIC IMAGING DEVICESMARKET 2014-2023 ($ MILLION)

37.        CANADA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

38.        UNITED KINGDOM (UK) DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

39.        FRANCE DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

40.        GERMANY DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

41.        SPAIN DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

42.        ITALY DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

43.        ROE DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

44.        INDIA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

45.        CHINA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

46.        JAPAN DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

47.        KOREA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

48.        AUSTRALIA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

49.        ROW APAC DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

50.        LATIN AMERICA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

51.        MENA DIAGNOSTIC IMAGING DEVICESMARKET2014-2023 ($ MILLION)

Request for Sample